A pilot observational study to assess the safety and efficacy of menoprogen for the management of menopausal symptoms in Chinese women

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 1, 2009, Pages 79-85

  Liu, Daniel ^a   Lu, Ye ^b   Ma, Hong ^c   Wei, Rong Cheng ^d   Li, Jingrong ^a   Fang, Jin ^e   Mahady, G B ^f  

^a Natural Herbal Farm Inc   (United States)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e Clinics of Ancient Acupuncture and Chinese Herbs   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ESTROGEN; FOLLITROPIN; HORMONE; LUTEINIZING HORMONE; MENOPROGEN; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CELL PROLIFERATION; CHINESE; CHINESE MEDICINE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRATAEGUS PINNATIFIDA; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HERB; HORMONE DETERMINATION; HUMAN; LAMINARIA JAPONICA; LUTEINIZING HORMONE BLOOD LEVEL; LYCIUM CHINENSIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MORUS ALBA; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SAFFLOWER; VAGINA CYTOLOGY;

ADULT; ANGIOSPERMS; CELL PROLIFERATION; CHINA; DRUGS, CHINESE HERBAL; FEMALE; HORMONES; HUMANS; MIDDLE AGED; PERIMENOPAUSE; PHYTOTHERAPY; PILOT PROJECTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; VAGINA;

EID: 58849126447     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0315     Document Type: Article

References (21)

1. Graziottin A, Leiblum SR. Biological and psycosocial pathophysiology of the female sexual dysfunction during the menopausal transition. J Sex Med 2005;2(suppl 3):133-145.
2. Writing Group for the Women's Health Initiative Investigators, WHI Working Group. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
3. Mahady GB. Black cohosh (Actaea/Cimicifuga racemosa): Review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 2005;4:177-184.
4. Lu Y, Ma H, Liu D. Pharmacological investigations of the unique herbal formula Menoprogen in rats: Estrogenic activity and mechanism. Gynecol Endocrinol 2008;24:161-170.
5. Wei R, Xu C. Effects of Menoprogen on menopausal symptoms. Pharm Adv 2004;28:521-523.
6. American College of Obstetricians and Gynecologists. Clinical Management Guidelines for Obstetrician-Gynecologists. Guideline for use of botanicals for management of menopausal symptoms. Obstet Gynecol 2001;97(suppl):1-11.
7. Alder E. The Blatt-Kupperman menopausal index: A critique. Maturitas 1998;29:19-24.
8. Chen G, Liu J. Estrogen alternative therapy for postmenopausal women. Chin J Obstet Gynecol 1995;30:123-127.
9. Liske E, Hänggi W, Henneicke-Van Zepelin HH, et al. Physiological investigation of a unique extract of black cohosh: A 6-month clinical study demonstrates no systemic estrogenic effect. J Women Health Gend Based Med 2002;11:163-174.
10. Warren MP, Biller BMK, Shangold MM. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-released vaginal gel crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. Am J Obstet Gynecol 1999;180:42-48.
11. Boulet MJ, Oddens BJ, Lehert P, Vemer HM, et al. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994;19:157-176.
12. McCrohon JA, Woo KS, Celermajer DS. A comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas 2000;35:31-37.
13. Gold EB, Sternfeld B, Kelsey JL, Brown C, et al. Relation of demographic and lifestyle factors to symptoms in a multiracial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473
14. Punyahotra S, Dennerstein L, Lehert P. Menopausal experiences of Thai women. Part 1: Symptoms and their correlates. Maturitas 1997;26:1-7.
15. Tang GWK. The climacteric of Chinese factory workers. Maturitas 1994;19:177-182.
16. Ma H, Lu Y. Clinical observation of Menoprogen for women with menopausal symptoms. Tianjin Med 2002;19:55-56.
17. Xie N, Lai R, Lu Y, Ma H. Overview of mechanism investigations of the postponement of ovarian senile and dysfunctions by herbal medicines in women with menopause. J Jiangsu Chin Traditional Med 2005;26:59-61.
18. Quirk SM, Porter DA, Huber SC, Cowan RG. Potentiation of Fas-mediated apoptosis of murine granulose cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide. Endocrinology 1998;139:4860-4869.
19. You J, Hu S. Impacts of apoptosis of granulosa follicles in mice by Dizheng granules. Bull Hunan Chin Traditional Med 2001;21:11-14.
20. Xiaofu L, Minghui J. Value of FSH, LH, FSH/LH ratio in the evaluation of ovarian function during perimenopausal period. J Zhengzhou Univ (Med Sci) 2005;4:123-125.
21. Macklon NS, Fauser BCJM. Follicle development during the normal menstrual cycle. Maturitas 1998;30:181-188.